<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Pharmion Corp. | Company News & Executive Profiles - PHRM | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/pharmion+corp..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Pharmion Corp.]]></description>
	<s:counts start="0" returned="10" found="22" />
	<language>en-us</language>
	<item>
		<title><![CDATA[RealPennies.com: Turning Pennies into dollars: (NASDAQ: PHRM); (OTCBB: UDHI); (OTCBB: ARRT).]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200802/ai_n25252625]]></link>
		<description><![CDATA[M2 PRESSWIRE-15 February 2008-RealPennies.com: RealPennies.com:  Turning Pennies into dollars: (NASDAQ: PHRM); (OTCBB: UDHI); (OTCBB:  ARRT).C1994-2008 M2 COMMUNICATIONS LTD     RDATE:15022008     Are you a public company looking for exposure? Contact  RealPennies.com - 1.800.940.6559     For more info: http://phrm.realpennies.com...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 15 Feb 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/dentist.html"><![CDATA[dentist]]></category>
		<category domain="http://resources.bnet.com/topic/ebay+inc..html"><![CDATA[eBay Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmion+corp..html"><![CDATA[Pharmion Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/u.s..html"><![CDATA[U.S.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EBAY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PHRM</category>
		<category domain="tickers">EBAY,NDAQ,PHRM</category>
	</item>
	<item>
		<title><![CDATA[German Federal Cartel Office Clears Celgene to Acquire Pharmion]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Jan_28/ai_n24231752]]></link>
		<description><![CDATA[SUMMIT, N.J. -- Celgene Corporation (NASDAQ: CELG) and Pharmion Corporation (NASDAQ: PHRM) announced that the Bundeskartellamt, Germany's Federal Cartel Office in charge of reviewing the antitrust aspects of mergers and acquisitions, has cleared Celgene's pending acquisition of Pharmion Corporation.  As previously announced on January 3, 2008, the 30-day waiting...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 28 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/celgene+corp..html"><![CDATA[Celgene Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmion+corp..html"><![CDATA[Pharmion Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CELG</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PHRM</category>
		<category domain="tickers">CELG,NDAQ,PHRM</category>
	</item>
	<item>
		<title><![CDATA[MethylGene Reports MGCD0103 Clinical Data at the 2008 Gastrointestinal Cancers Symposium; Data from Phase I/II MGCD0103 combination trial with Gemzar(R) in patients with solid tumors Phase II portion of the clinical trial in pancreatic cancer patients ong]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200801/ai_n22584346]]></link>
		<description><![CDATA[MONTREAL, QUEBEC, Jan 28, 2008 Marketwire via COMTEX --  MethylGene Inc. (TSX:MYG), along with its collaborator Pharmion  Corporation (NASDAQ:PHRM), today updated clinical data from the  Companies' MGCD0103 Phase I/II combination trial with GemzarR   MONTREAL, QUEBEC, Jan 28, 2008 Marketwire via COMTEX --  MethylGene Inc....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 28 Jan 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/clinical+trial.html"><![CDATA[clinical trial]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/pharmion+corp..html"><![CDATA[Pharmion Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PHRM</category>
		<category domain="tickers">PHRM</category>
	</item>
	<item>
		<title><![CDATA[Methylgene and Pharmion Start Phase II Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200801/ai_n21185016]]></link>
		<description><![CDATA[MethylGene Inc. (TSX: MYG) and Pharmion Corporation (NASDAQ: PHRM) today announced the enrollment of the first patient in a Phase II clinical trial (Trial 012) evaluating MGCD0103, the Companies' isotype-selective histone deacetylase inhibitor HDACi product candidate, in combination with VidazaŽ azacitidine for injection, Pharmion's DNA demethylating agent, in patients with...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 09 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[cell]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/dna.html"><![CDATA[DNA]]></category>
		<category domain="http://resources.bnet.com/topic/nhl.html"><![CDATA[NHL]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/pharmion+corp..html"><![CDATA[Pharmion Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PHRM</category>
		<category domain="tickers">PHRM</category>
	</item>
	<item>
		<title><![CDATA[Methylgene and Pharmion Start Phase II Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200801/ai_n22581835]]></link>
		<description><![CDATA[MONTREAL, QUEBEC and BOULDER, COLORADO, Jan 9, 2008 Marketwire via  COMTEX -- MethylGene Inc. (TSX:MYG) and Pharmion Corporation  (NASDAQ:PHRM) today announced the enrollment of the first patient in a  Phase II clinical trial (Trial 012) evaluating MGCD0103, the  Companies' isotype-selective histone deacetylase inhibitor HDACi  product...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 09 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/cell.html"><![CDATA[cell]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/dna.html"><![CDATA[DNA]]></category>
		<category domain="http://resources.bnet.com/topic/nhl.html"><![CDATA[NHL]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/pharmion+corp..html"><![CDATA[Pharmion Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PHRM</category>
		<category domain="tickers">PHRM</category>
	</item>
	<item>
		<title><![CDATA[Celgene/Pharmion Hart-Scott-Rodino  Thirty Day Waiting Period Expires]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Jan_3/ai_n27487532]]></link>
		<description><![CDATA[SUMMIT, N.J. & BOULDER, Colo. -- Celgene Corporation (NASDAQ: CELG) and Pharmion Corporation (NASDAQ: PHRM) today jointly announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, has expired without the United States Federal Trade Commission requesting additional information with regard to Celgene's pending acquisition...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 03 Jan 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/celgene+corp..html"><![CDATA[Celgene Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/pharmion+corp..html"><![CDATA[Pharmion Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CELG</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PHRM</category>
		<category domain="tickers">CELG,PHRM</category>
	</item>
	<item>
		<title><![CDATA[Pharmion Q3 2007 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-232251.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions And your first question comes from the line of Gene Mack of HSBC Securities. Please proceed. Gene Mack - HSBC Thanks for taking the question. I apologize for the bad connection, but that actually your fault for having this during prime trick-or-treating hours. Patrick Mahaffy...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 31 Oct 2007 19:03:34 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/pharmion+corp..html"><![CDATA[Pharmion Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PHRM</category>
		<category domain="tickers">PHRM</category>
	</item>
	<item>
		<title><![CDATA[MethylGene and Pharmion Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Hodgkin's Lymphoma.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5559/is_200708/ai_n22564700]]></link>
		<description><![CDATA[MONTREAL, QUEBEC and BOULDER, COLORADO, Aug 21, 2007 CCNMatthews  via COMTEX -- MethylGene Inc. (TSX:MYG), along with its collaborator  Pharmion Corporation (NASDAQ:PHRM), today announced that the U.S. Food  and Drug Administration FDA has designate  MONTREAL, QUEBEC and BOULDER, COLORADO, Aug 21, 2007 CCNMatthews  via COMTEX...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 21 Aug 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pharmion+corp..html"><![CDATA[Pharmion Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PHRM</category>
		<category domain="tickers">PHRM</category>
	</item>
	<item>
		<title><![CDATA[Wall Street News Alert: ELHI Is Friday's Stock to Watch! August 3, 2007]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200708/ai_n19429007]]></link>
		<description><![CDATA[Wall Street News Alert's "stocks to watch" this morning are: Edgeline Holdings, Inc. (OTCBB: ELHI), Pharmion Corporation (NASDAQ: PHRM), BluePhoenix Solutions Ltd. (NASDAQ: BPHX) and FiberTower Corporation (NASDAQ: FTWR).  Investors looking to benefit from high technology sectors should have a close eye on Edgeline Holdings, Inc. (OTCBB: ELHI). Thursday...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 03 Aug 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/fibertower+corp..html"><![CDATA[FiberTower Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/networking.html"><![CDATA[NETWORKING]]></category>
		<category domain="http://resources.bnet.com/topic/pharmion+corp..html"><![CDATA[Pharmion Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/secure.html"><![CDATA[Secure]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/technology.html"><![CDATA[technology]]></category>
		<category domain="http://resources.bnet.com/topic/telecommunications.html"><![CDATA[TELECOMMUNICATIONS]]></category>
		<category domain="http://resources.bnet.com/topic/voip.html"><![CDATA[VOIP]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FTWR</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PHRM</category>
		<category domain="tickers">FTWR,NDAQ,PHRM</category>
	</item>
	<item>
		<title><![CDATA[Market Pulse.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200708/ai_n19776504]]></link>
		<description><![CDATA[M2 PRESSWIRE-2 August 2007-Bullishalerts.com: Market  PulseC1994-2007 M2 COMMUNICATIONS LTD    RDATE:02082007    Philadelphia, PA - Bullish Alerts is currently monitoring the  following Stocks: Nuvelo, Inc. (Nasdaq: NUVO), 8x8, Inc. (Nasdaq: EGHT),  Discovery Laboratories, Inc. (Nasdaq: DSCO) and Pharmion Corporation  (Nasdaq: PHRM) ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 02 Aug 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/8x8+inc..html"><![CDATA[8x8 Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nuvelo+inc..html"><![CDATA[Nuvelo Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/packet8.html"><![CDATA[Packet8]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/pharmion+corp..html"><![CDATA[Pharmion Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EGHT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NUVO</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PHRM</category>
		<category domain="tickers">EGHT,NDAQ,NUVO,PHRM</category>
	</item>
</channel>
</rss>
